138 related articles for article (PubMed ID: 3715961)
41. Representation of older patients in cancer treatment trials.
Trimble EL; Carter CL; Cain D; Freidlin B; Ungerleider RS; Friedman MA
Cancer; 1994 Oct; 74(7 Suppl):2208-14. PubMed ID: 8087794
[TBL] [Abstract][Full Text] [Related]
42. Family cancer history: healthy skepticism required.
Freedman RA; Garber JE
J Natl Cancer Inst; 2011 May; 103(10):776-7. PubMed ID: 21562244
[No Abstract] [Full Text] [Related]
43. Clinical course of the most common malignancies.
Cruz J
Med Sect Proc; 1989; ():81-93. PubMed ID: 2641558
[No Abstract] [Full Text] [Related]
44. Cancer statistics, 1998.
Landis SH; Murray T; Bolden S; Wingo PA
CA Cancer J Clin; 1998; 48(1):6-29. PubMed ID: 9449931
[TBL] [Abstract][Full Text] [Related]
45. Cancer incidence in the Netherlands Antilles: a survey covering the period 1968--1979.
Freni SC; Freni-Titulaer LW
Cancer; 1981 Dec; 48(11):2535-41. PubMed ID: 7296503
[TBL] [Abstract][Full Text] [Related]
46. [Critical interpretation of the cancer incidence increase in France].
Hill C
Med Sci (Paris); 2009 Mar; 25(3):297-9. PubMed ID: 19361395
[No Abstract] [Full Text] [Related]
47. Statistics: Attacking an epidemic.
May M
Nature; 2014 May; 509(7502):S50-1. PubMed ID: 24870819
[No Abstract] [Full Text] [Related]
48. Epidemiological outlook on cancer.
Curnen MG
Bull N Y Acad Med; 1978 Apr; 54(4):349-65. PubMed ID: 274970
[No Abstract] [Full Text] [Related]
49. A male-female differential in tumour incidence.
Ashley DJ
Br J Cancer; 1969 Mar; 23(1):21-5. PubMed ID: 5768438
[No Abstract] [Full Text] [Related]
50. The face of cancer in the United States.
Fraumeni JF
Hosp Pract (Off Ed); 1983 Dec; 18(12):81-5, 89-96. PubMed ID: 6417002
[No Abstract] [Full Text] [Related]
51. [Cancer incidence in the Altai Republic].
Odintsova IN; Pisareva LF; Ananina OA; Khriapenkov AV; Cherdyntseva NV
Vopr Onkol; 2014; 60(4):464-8. PubMed ID: 25552065
[TBL] [Abstract][Full Text] [Related]
52. Trends in cancer mortality and epidemiology.
Miller AB
Cancer; 1983 Jun; 51(12 Suppl):2413-8. PubMed ID: 6850518
[TBL] [Abstract][Full Text] [Related]
53. Testing the light-at-night (LAN) theory for breast cancer causation.
Stevens RG
Chronobiol Int; 2011 Oct; 28(8):653-6. PubMed ID: 21929297
[No Abstract] [Full Text] [Related]
54. Disparity in cancer statistics changing.
Mitka M
JAMA; 2002 Feb; 287(6):703-4. PubMed ID: 11851516
[No Abstract] [Full Text] [Related]
55. Additional malignant neoplasms in patients with breast carcinoma.
Lee YT
J Surg Oncol; 1986 Mar; 31(3):199-203. PubMed ID: 3724172
[TBL] [Abstract][Full Text] [Related]
56. Cancer in the elderly.
Serpick AA
Hosp Pract; 1978 Feb; 13(2):101-7, 111-2. PubMed ID: 631830
[No Abstract] [Full Text] [Related]
57. [Cancer in old age].
Borchard-Tuch C
Med Monatsschr Pharm; 2014 Jan; 37(1):27-9. PubMed ID: 24490435
[No Abstract] [Full Text] [Related]
58. Epidemiologic leads to cancer control in India.
Nair MK; Sankaranarayanan R
Cancer Causes Control; 1991 Jul; 2(4):263-5. PubMed ID: 1873456
[No Abstract] [Full Text] [Related]
59. Cancer epidemiology: shortcomings and possibilities.
Clemmesen J
Environ Health Perspect; 1983 Apr; 50():329-38. PubMed ID: 6873023
[TBL] [Abstract][Full Text] [Related]
60. Norepinephrine antagonists and cancer risk.
Friedman GD; Udaltsova N; Habel LA
Int J Cancer; 2011 Feb; 128(3):737-8; author reply 739. PubMed ID: 20333678
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
